PHARMACT

Pharmact is a medtech company focusing on preventing disease through early detection. The company's international team of medical experts provides healthcare professionals with qualitative point-of-care rapid tests for the early detection of chronic diseases such as type 2 diabetes mellitus and liver fibrosis, as well as acute myocardial infarction... To help tackle the COVID-19 global pandemic, Pharmact has developed a highly sensitive and accurate antibody test. The BELTEST-IT COV-2 Rapid Test is an immunochromatographic test for the qualitative detection of immunoglobins M (IgM) and G (IgG) against the SARS-CoV-2 virus in human whole blood and serum. The test assists in determining possible immune reaction against coronavirus infection... We are committed to improving the health of the global community through the early diagnosis of chronic disease.

Also known as: Pharmact GmbH, Pharmact Healthcare Inc., Pharmact Holding AG

Registration numbers: 3016467896 (W), HRB 733657 (W)

VAT numbers: DE324832035

Primary location: Mannheim Chile